Web Analytics

In observance of Memorial Day, Genway Biotech office will be closed on Monday, May 28th, 2018

RC-160 (Vapreotide)

GWB-133358

06-271-83436

$0.00
Add to Cart

Description

Sequence (One Letter Code): FCYWKVCW-NH

Sequence: {d-PHE} {CYS} {TYR} {d-TRP} {LYS} {VAL} {CYS} {TRP}-NH2 C Terminal: NH2

Formula: C57H70N12O9S2 Chemical Bridge: Disulfide bridge: Cys2-Cys7

Solubility: Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents. RC-160 (octastatin/vapreotide) is a potent octapeptide analogue of somatostatin with growth inhibitory activity in experimental tumours in vitro and in vivo. including breast cancer. high-dose RC-160. can reduce serum levels of the breast growth factors IGF-I and prolactin but is ineffective in the management of metastatic breast cancer. Encouraging preclinical anti-tumour activity and the favourable toxicity profile in patients suggest the merit of future studies combining RC-160 with anti-oestrogen. cytotoxic and anti-angiogenic agents.

N/A

Additional Information

Name RC-160 (Vapreotide)
Related Product Names RC-160 (Vapreotide)
Molecular Weight 35825
Datasheets / Downloads GWB-133358 Datasheet
Swiss Prot Number Q8KW30
Purity > 95%
Stability 6-12 months at -20 degree C.
Storage 4 degree C for short term (weeks) and -20 degree C for long term.
Intended Use Research Use Only